Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost efficacy and tolerability in glaucoma or ocular hypertension
2005-002252-18Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Nov 2005
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of travoprost in open-angle glaucoma (OAG) and ocular hypertension, sponsored by Alcon Inc. Primary endpoint: Intraocular pressure reduction. Started Nov 2005; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2005-002252-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002252-18.